These findings demonstrate the role of C1orf122 in HCC development via the SRPK1-PI3K/AKT/GSK3β axis, highlighting its potential as a diagnostic or therapeutic target for HCC (Fig. 7). This evidence concerns the gene GSK3B and hepatocellular carcinoma.